In the latest session, Avenue Therapeutics Inc (NASDAQ: ATXI) closed at $0.17 down -0.65% from its previous closing price of $0.17. In other words, the price has decreased by -$0.0011 from its previous closing price. On the day, 2287552 shares were traded.
Ratios:
For a deeper understanding of Avenue Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.04 and its Current Ratio is at 0.04.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 11 ’23 when Davidow Robert L sold 353,000 shares for $0.14 per share. The transaction valued at 49,600 led to the insider holds 22,000 shares of the business.
Davidow Robert L sold 264,000 shares of ATXI for $36,960 on Dec 11 ’23. The 10% Owner now owns 681,000 shares after completing the transaction at $0.14 per share. On Sep 08 ’23, another insider, Fortress Biotech, Inc., who serves as the 10% Owner of the company, bought 418,410 shares for $0.72 each. As a result, the insider paid 301,255 and bolstered with 1,032,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXI now has a Market Capitalization of 6.27M and an Enterprise Value of 6.11M.
Stock Price History:
Over the past 52 weeks, ATXI has reached a high of $1.36, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.1565, while the 200-Day Moving Average is calculated to be 0.5990.
Shares Statistics:
For the past three months, ATXI has traded an average of 5.25M shares per day and 1.6M over the past ten days. A total of 37.31M shares are outstanding, with a floating share count of 32.47M. Insiders hold about 12.96% of the company’s shares, while institutions hold 3.32% stake in the company. Shares short for ATXI as of Feb 15, 2024 were 337.74k with a Short Ratio of 0.06, compared to 1.11M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.91% and a Short% of Float of 0.91%.
Earnings Estimates
There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.11, while EPS last year was $0.26. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.79 and -$1.16 for the fiscal current year, implying an average EPS of -$0.97. EPS for the following year is -$0.41, with 1 analysts recommending between -$0.41 and -$0.41.
